1
|
Shao X, Ekstrand DHL, Bhikhabhai R, Kallander CFR, Gronowitz JS. A Non-Radioactive Microtitre Plate Reverse Transcriptase (RT) Assay, Based on Immobilized Template, for Screening of RT Activity Inhibitors and Evaluation of their Mode of Action. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/095632029700800209] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A new sensitive colorimetric reverse transcriptase (RT) activity assay utilizing a 96-well microtitre plate format, with solid phase-conjugated polyadenylic acid (prA), was investigated for simple analyses of the RT inhibiting capacity and mode of action of various substances. Three different technical procedures using the assay were evaluated: (i) direct lC50 determinations with various substances, using four different combinations of primer and dNTP amounts; (ii) analyses of the capacity of the substances to interfere with the binding of RT to template or template-primer (BIC50); (iii) analyses of the capacity of the substances to destroy the template-primer in presence or absence of RT (TDC50). The assay was found to be useful for all three purposes using small amounts of recombinant RT. In the IC50 analyses, the test substances gave values similar to those reported for soluble RT assays, and the values varied in accordance with their known mode of action in relation to the combination of primer and dNTP amount used. Only one of the substances, prG, in addition to DNA and RNA gave true RT binding inhibition. The template destruction assay showed that chain terminating substances gave destruction at low inhibitor concentrations. Furthermore, this destruction was RT-dependent, in contrast to the destruction obtained with substances that can base-pair with the template or primer. For optimum information on mode of action of a given substance all three assay procedures should be used. The use of the assay in relation to the screening and analyses of new RT inhibitory substances and characterization of RT in primary isolates or plasma is discussed.
Collapse
Affiliation(s)
- X Shao
- The Research Unit for Replication Enzymology, Department of Medical Genetics, Uppsala University, BMC, Box 584, 751 23 Uppsala, Sweden
- Department of Virology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing 100050, China
| | - DHL Ekstrand
- The Research Unit for Replication Enzymology, Department of Medical Genetics, Uppsala University, BMC, Box 584, 751 23 Uppsala, Sweden
| | | | - CFR Kallander
- The Research Unit for Replication Enzymology, Department of Medical Genetics, Uppsala University, BMC, Box 584, 751 23 Uppsala, Sweden
- Cavidi Tech, Uppsala Science Park, Glunten, (Staben), 751 83 Uppsala, Sweden
| | - JS Gronowitz
- The Research Unit for Replication Enzymology, Department of Medical Genetics, Uppsala University, BMC, Box 584, 751 23 Uppsala, Sweden
- Cavidi Tech, Uppsala Science Park, Glunten, (Staben), 751 83 Uppsala, Sweden
| |
Collapse
|
2
|
Corrigan GE, Al-Khalili L, Malmsten A, Thorstensson R, Fenyö EM, Källander CF, Gronowitz JS. Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains. AIDS Res Hum Retroviruses 1998; 14:347-52. [PMID: 9519896 DOI: 10.1089/aid.1998.14.347] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Failure to detect infection with HIV-1 non-B subtypes in some antibody screening assays has been shown. To date, however, no studies have been published evaluating the capacity of standard tests to quantify replication of divergent HIV-1 in cell culture. Reverse transcriptase (RT) activity and p24 antigen assays are the two methods most commonly used for this purpose. A homogeneous panel of HIV-1 subtype B viruses from northern Italy and a heterogeneous panel of diverse genetic subtypes (A to F and O) from different regions of the world were cultured under identical conditions. A new nonradioactive RT assay was used as a basis for comparison to evaluate the capacity of two p24 assays to quantify viral growth in both panels. Comparison of the p24 amount/RT activity (p24/RT) ratios showed that ratios in the subtype B panel tended to be markedly higher than in the diverse subtype panel. Greatest variation was seen with one of the subtype O isolates, where up to a 400 times lower ratio was obtained compared with the average ratio for the subtype B panel. In addition, one Thai subtype B virus also gave a markedly reduced ratio. Furthermore, comparison between the two p24 assays showed different abilities to detect p24 from different HIV-1 isolates. We discuss limitations for the use of anti-HIV-1 p24 antibodies produced by immunization with subtype B p24 in p24 assays.
Collapse
Affiliation(s)
- G E Corrigan
- Cavidi Tech AB, Uppsala Science Park, Staben, Sweden
| | | | | | | | | | | | | |
Collapse
|
3
|
Lennerstrand J, Rytting AS, Vrang L, Gronowitz J, Källander C. Application of a Chain Termination Assay for Characterization of Reverse Transcriptase from AZT-Resistant HIV Isolates. Antivir Chem Chemother 1996. [DOI: 10.1177/095632029600700604] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
An enzymatic assay based on utilization of one primer/enzyme molecule was specifically designed for evaluation of the chain termination capacity of reverse transcriptase (RT) from HIV-1 isolates. In this assay system (CT assay) there was a 3.2-fold difference between the AZT-triphosphate (AZT-TP) concentrations required to terminate 50% of the primers (TC50) for a highly resistant isolate, carrying the four common mutations at positions 67, 70, 215, and 219; and two wild type isolates. Two of three other isolates with reduced sensitivity to AZT in cell culture exhibited intermediate values in CT assay, while one behaved as the wild type isolates. There was a correlation P = 0.05 ( r = 0.86, n = 6) between the ED50values found in cell culture and the TC50values found in CT assay. This relationship was not found in a similar assay system which measured competition between AZT-TP and 1 μM tymidine triphosphate (TTP) at the enzymatic level. The sequence data of the current isolates gave some information concerning which mutations in the RT gene specifically affect the enzymatic properties measured in CT assay. Mutation only at amino acid 70 had no effect, but the TC50values found increased with accumulation of the other common AZT resistance mutations.
Collapse
Affiliation(s)
- J. Lennerstrand
- The Research Unit of Replication Enzymology, Department of Medical Genetics, the Biomedical Centre, Box 584, S-751 23, Uppsala University, Sweden
- Sangtec Medical AB, Box 20045, S-16120, Bromma, Sweden
| | - A.-S. Rytting
- The Research Unit of Replication Enzymology, Department of Medical Genetics, the Biomedical Centre, Box 584, S-751 23, Uppsala University, Sweden
| | - L. Vrang
- Medivir AB, Lunastigen 7, S-14144 Huddinge, Sweden
| | - J.S. Gronowitz
- The Research Unit of Replication Enzymology, Department of Medical Genetics, the Biomedical Centre, Box 584, S-751 23, Uppsala University, Sweden
| | - C.F.R. Källander
- The Research Unit of Replication Enzymology, Department of Medical Genetics, the Biomedical Centre, Box 584, S-751 23, Uppsala University, Sweden
| |
Collapse
|
4
|
Palmer S, Harmenberg J, Cox S. Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine. Antimicrob Agents Chemother 1996; 40:1285-8. [PMID: 8723486 PMCID: PMC163311 DOI: 10.1128/aac.40.5.1285] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
The combinations of foscarnet plus 2',3'-dideoxyinosine and foscarnet plus 2',3'-dideoxycytidine synergistically inhibit the replication of human immunodeficiency virus type 1 isolates, including two 3'-azido-3'-deoxythymidine-resistant isolates. The combination of 2',3'-dideoxyinosine plus 2',3'-dideoxycytidine showed additive inhibition of the majority of the human immunodeficiency virus isolates tested. All three combinations showed pronounced antagonistic cytotoxicity and thus were less toxic to the growth of peripheral blood mononuclear cells than the separate drugs.
Collapse
Affiliation(s)
- S Palmer
- Virology Department, Swedish Institute for Infectious Disease Control, Stockholm, Sweden
| | | | | |
Collapse
|